Pfizer Vaccine For Kids May Not Be Approved Until November

The Wall Street Journal reports that Pfizer's application for FDA approval of a low-dose COVID-19 vaccine for children aged 5 to 11 is delayed. Originally aiming for approval by October, Pfizer submitted its data recently, but the full application may not be completed until mid-October. Consequently, the FDA's decision might be postponed until closer to Thanksgiving.

What was Pfizer's original goal regarding the vaccine for kids?

What age group is Pfizer targeting for the low dose vaccine?

When did Pfizer submit its data to the FDA?

What might delay the decision on the approval application?

What is the potential timeline for a decision on the vaccine approval?